Clinical Trial Update: MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update showing results for MLN4924 (pevonedistat) in acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• MLN4924 (pevonedistat) (pevonedistat)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED